Results 191 to 200 of about 200,878 (264)

Epigenetic regulation of breast ductal carcinoma in situ by miR-217 through DNMT1 and Hedgehog-GLI pathway. [PDF]

J Cell Commun Signal
Wang Z, Wu L, Lai S, Guo S, Pu C, Zhang L, Li X.   +6 more
europepmc   +1 more source

A cost‐effectiveness analysis of breast cancer treatment in certified versus non‐certified hospitals in Germany

International Journal of Cancer, EarlyView.
What's New? This study is the first to quantify the cost‐effectiveness of breast cancer treatment in German Cancer Society‐certified hospitals using real‐world data from over 140,000 patients. Analysis on certification‐related costs and survival outcomes demonstrates that high‐quality multidisciplinary care at certified hospitals delivers substantial ...
Min‐Wai Lwin, Olaf Schoffer, Christoph Streissnig, Pauline Wimberger, Michael Gerken, Veronika Bierbaum, Christoph Bobeth, Martin Rößler, Patrik Dröge, Thomas Ruhnke, Christian Günster, Kees Kleihues‐van Tol, Theresa Link, Anton Scharl, Elisabeth C. Sturm‐Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt, Michael Schlander   +20 more
wiley   +1 more source

Postoperative radiotherapy for ductal carcinoma in situ: survival prediction and clinical decision support using a nomogram-based approach. [PDF]

Sci Rep
Wang Y, Zhang J, Wu Y, Liang Y.
europepmc   +1 more source

High acceptability of point‐of‐care HIV testing at the colposcopy outpatient clinic in hospitals in the Netherlands

International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 155-162, April 2025.
Abstract Objective Cervical cancer and its precursor are labeled as HIV indicator conditions, justifying the recommendation of HIV testing for all patients. This study aimed to assess the acceptance and patients' and gynecologists' perceptions on HIV testing in patients with cervical dysplasia at the colposcopy outpatient clinic in hospitals in the ...
R. L. O. van de Laar, C. C. E. Jordans, A. Salmaan, W. Hofhuis, S. A. H. M. van den Tillaart, I. A. M. van der Avoort, P. J. Timmers, H. J. van Beekhuizen, H. C. van Doorn, C. Rokx   +9 more
wiley   +1 more source

NMD-insensitive CDH1 mutation as a mechanism for retained E-cadherin protein expression in lobular carcinoma in situ (LCIS). [PDF]

Histopathology
Christgen M, Bartels S, Kreipe H.
europepmc   +1 more source

Quality of Life Among Patients With Ductal Carcinoma In Situ.

JAMA Netw Open
Dunsmore VJ, Snyder BS, Gareen IF, Lehman CD, Khan SA, Romanoff J, Gatsonis C, Corsetti RL, Rahbar H, Spell DW, Han LK, Bumberry JR, Miller KD, Sparano JA, Comstock C, Park E, Wagner LI, Carlos RC.   +17 more
europepmc   +1 more source

Cause-specific mortality after a diagnosis of ductal carcinoma in situ: Associations with screening and socio-economic status. [PDF]

Int J Cancer
Schmitz RSJM, van den Belt-Dusebout AW, van Seijen M, Verschuur EAJ, van Duijnhoven FH, Schaapveld M, Lips EH, Wesseling J, Schmidt MK.   +8 more
europepmc   +1 more source

SARS-CoV-2 infection heightens the risk of developing HPV-related carcinoma in situ and cancer. [PDF]

Discov Oncol
Shih YH, Yang CY, Lung CC.
europepmc   +1 more source

Ductal Carcinoma In Situ of the Breast: An Analysis of 12 Years of Experience From a Tertiary Center. [PDF]

Cureus
Tepetam H, Hanilce MM, Dursun CU, Gedik D, Karabulut Gul S.   +4 more
europepmc   +1 more source

Assessment of Human Epididymis Protein 4 Expression in Breast Ductal Carcinoma In Situ. [PDF]

Diagnostics (Basel)
Kim NI, Park MH, Lee JS.
europepmc   +1 more source